WHO says contaminated medicines manufactured by Pakistani pharma identified in some regions
- WHO says medicines contained ‘unacceptable levels’ of contaminant ethylene glycol
- Affected products identified in Americas, Eastern Mediterranean, South East Asia, Western Pacific